Next week, at the Perth Convention and Exhibition Centre, The Royal Australian and New Zealand College of Psychiatrists (RANZCP) meet for the RANZCP 2023 Congress on the theme of “New Horizons: Connected Futures”
Delegates have been invited to reflect on how interconnectedness is a strength; and connections with each other in personal and professional lives, connections with the diverse cultures in communities, and connection to place with First Nations people.
Looking forward delegates have been asked to consider the next horizon in biological psychiatry and the delivery of evidence-based treatments. They have been asked to consider how the criminal justice system, mental healthcare system, disability sector and drug and alcohol services are interwoven and how to provide care that is integrated, and person centred.
Australian Health Journal spoke to current President-Elect Dr Elizabeth Moore and soon to be President, RANZCP about the Congress, as well as the recent Federal Budget announcements around mental health funding.
The RANZCP has welcomed a number of measures:
- $260.2 million over two years from 2023–24 to extend Commonwealth psychosocial supports for people with severe mental illness who are not in the National Disability Insurance Scheme (NDIS)
- $0.9 million over two years from 2022–23 to develop a 10 Year National Action Plan to support the health and wellbeing of Lesbian, Gay, Bisexual, Transgender, Intersex, Queer and Asexual (LGBTIQA+) people and establish a LGBTIQA+ Health Advisory Group.
- $40.0 million over 4 years from 2023–24 to establish the National Clinical Quality Registry Program for tracking the safety and performance of treatments and devices, thereby improving performance reporting for clinicians and hospitals.
- $4.9 billion over 5 years from 2022–23 (with $1.3 billion per year ongoing) to increase support for people receiving working age payments including the JobSeeker Payment. As noted in the College’s submission to the Senate Inquiry into poverty in Australia, we urged for an increase to the allowance rate for Australians accessing government-funded payments, including JobSeeker.
However, while there are some positive measures for mental health, RANZCP believe funding has been weighted to wellbeing initiatives and primary care. Australians experiencing the most serious mental health conditions, with severe, complex and chronic presentations have missed out on vital support in this year’s Federal Budget.
A particular group of concern is children. Around 3 in 4 children with a severe mental health disorder are missing out on critical support, according to Dr Moore.
Out of the 80,000 children in Australian with a severe mental health condition, only 22,000 are currently being seen by a psychiatrist, stating the case that more child and adolescent psychiatrists are needed to meet the needs of children.
-
Inaugural report into Australasian Paramedicine Workforce Survey report to aid workforce planning
In a milestone for paramedicine, the Australasian College of Paramedicine earlier this year released the first report of a landmark three-year study identifying and exploring trends that affect the Australasian paramedicine workforce.
The inaugural Australasian Paramedicine Workforce Survey report 2023-24 explores the demographic, career trajectory, work motivations and conditions for those working in clinical, management and educational capacities within the paramedicine workforce of Australia and Aotearoa New Zealand. -
Medicinal cannabis in Australia Update
According to the Australian Journal of General Practice, published by the Royal Australian College of General Practitioners, more than 130,000 medicinal cannabis approvals have been issued in Australia to date, mostly by general practitioners, with approximately 65% of these to treat chronic non-cancer pain. Despite robust supportive data from animal models, current clinical trial evidence for THC and CBD efficacy in chronic pain is incomplete. In their prescribing decisions, doctors must balance patient demand and curiosity with caution regarding potential risks and limited efficacy.
Australian Health Journal met with 3 speakers at the recent ARCS22 Conference providing an update on medicinal cannabis. The discussion with the speakers now centres on affordability and access.
-
Research funded to investigate early-onset bowel cancer progression
Bowel Cancer Australia recently announced a team led by Professor Michael Samuel as the successful applicant for a three-year $600k early-onset bowel cancer research project through the 2023 round of Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme (PdCCRS).
